 He was first introduced to the field of Coenzyme Q10 clinical research by Dr. Karl Folkers, the American bio-chemist who determined the structure of the Coenzyme Q10 molecule.Judy has managed randomized controlled trials into the safety and efficacy of Coenzyme Q10 supplementation for heart failure patients, chronic fatigue syndrome patients, Parkinson's disease patients, and prostate cancer patients.He has been instrumental in the treating of children with Prader-Willi syndrome with Coenzyme Q10.